<DOC>
	<DOC>NCT01044212</DOC>
	<brief_summary>The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.</brief_summary>
	<brief_title>Bowel Function After Minimally Invasive Urogynecologic Surgery</brief_title>
	<detailed_description>See above</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<criteria>Planning to be admitted to the hospital to undergo minimallyinvasive urogynecologic surgery at Strong Memorial Hospital. Procedures may include: robotassisted laparoscopic sacrocolpopexy sacrospinous ligament suspension uterosacral ligament suspension/paravaginal defect repair colpocleisis cystocele repair Additional procedures may include: hysterectomy adnexectomy culdoplasty minimally invasive sling procedure (TVT or TOT) periurethral collagen injections enterocele repair Planning to undergo laparotomy. Undergoing rectocele or perineocele repair as part of surgery. Taking Miralax, laxatives, enemas, or suppositories daily, at the time of enrollment. Presence of a colostomy. Chronic kidney disease Insulindependent diabetes mellitus Known cardiac disease Gastric ulcers Difficulty swallowing or esophageal stricture Persistent nausea and vomiting Signs and symptoms consistent with bowel obstruction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Urogynecology</keyword>
</DOC>